Test Price
2,800 AED✅ Home Collection Available
SOX3 Gene NGS Test – X-Linked Intellectual Disability & Isolated Growth Hormone Deficiency
Executive Summary & Core Metrics
- Test: SOX3 Gene NGS Panel (X-linked intellectual disability with isolated GH deficiency)
- Price: AED 2,800 (all-inclusive, no hidden fees)
- Turnaround Time: 21–28 calendar days
- Accuracy: >99.9% analytical sensitivity (ISO 9001:2015, Cert: INT/EGQ/2509DA/3139)
- Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM – 11 PM)
- Post‑Test: Complimentary telephonic consultation with DHA‑licensed genetic counsellor
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The SOX3 Gene NGS Test employs next‑generation sequencing (Illumina platform) to identify pathogenic variants in the SOX3 gene responsible for X‑linked intellectual disability accompanied by isolated growth hormone deficiency. This targeted panel covers all coding exons, flanking intronic regions, and detects copy number variations (CNVs) that Sanger sequencing cannot resolve. Clinical validation against orthogonal ddPCR confirms >99.9% sensitivity and specificity.
| Feature | Our Test (SOX3 NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | >99.9% sensitivity; full gene coverage (coding + flanking introns) | ~98% sensitivity; limited to known exons only |
| Method | Next‑Generation Sequencing (Illumina platform) with clinical‑grade bioinformatics | Sanger sequencing – lower throughput, no CNV detection |
| Turnaround | 21–28 calendar days | 6–8 weeks typical |
Physician Insight & Safety Protocols
“The emotional journey of investigating an inherited neuroendocrine disorder demands both precision and empathy. As a DHA‑licensed Consultant Medical Geneticist, I emphasize that this test provides a molecular diagnosis, but results must be interpreted in the context of clinical presentation and family history. A negative NGS result does not exclude the condition; comprehensive endocrine and neurological follow‑up remains indispensable. Our team provides step‑by‑step guidance throughout the process.”
— Lina Osama Zaki Quteineh (DHA: 9294403)
Medication Advisory
Patients prescribed growth hormone therapy or neurological medications must not discontinue or modify treatment without explicit guidance from their treating physician. Abrupt cessation may lead to adrenal crisis or exacerbation of seizure activity. Always consult your specialist before any change.
Patient Exclusion Criteria & Emergency Red Flags
- Testing is not validated for incidental findings; only individuals with a clinical indication for SOX3 evaluation should proceed.
- Minors (under 18) must be accompanied by a legal guardian; mandatory genetic counselling consent applies per Federal Decree‑Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019.
- Active febrile illness or recent blood transfusion (within 14 days) may compromise DNA extraction quality.
- ER Red Flags: Sudden loss of consciousness, severe headache, visual field defects, or hyponatremia require immediate emergency care—do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the clinical accuracy of the SOX3 NGS test for mental retardation and growth hormone deficiency?
Our NGS panel achieves >99.9% analytical sensitivity and specificity for SOX3 coding variants, validated by orthogonal ddPCR at our CAP‑accredited laboratory. Diagnostic yield in affected males with typical phenotype exceeds 85%, while carrier testing in females identifies heterozygous deletions often missed by routine karyotyping.
2. How should I prepare for the SOX3 gene NGS test?
No fasting is required. A 3–5 mL whole blood sample (EDTA) or a dried blood spot on an FTA card is collected. Pre‑test genetic counselling is mandatory to document the pedigree and discuss X‑linked inheritance implications. Continue all prescribed medications unless your physician advises otherwise. Our VIP mobile phlebotomy team handles collection at your preferred location between 8 AM and 11 PM daily.
3. How long does it take to receive SOX3 test results and what happens after?
Results are available within 21–28 calendar days and are delivered via a secure encrypted portal. A DHA‑licensed genetic counsellor provides a 30‑minute post‑test telephonic consultation to explain the genetic findings, implications for family members, and integration with endocrine management plans—all included in the fee.
UAE Regulatory & Data Privacy Adherence
All patient data handling complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genetic results are encrypted end‑to‑end, accessible only by authorized clinicians and the patient. The laboratory operates under DHA Facility License Number 1143, ensuring strict adherence to national standards for medical confidentiality and clinical governance.
Clinical & Logistical Metadata
| Test Name | SOX3 Gene NGS Panel (X-Linked Intellectual Disability & Growth Hormone Deficiency) |
| Price (AED) | AED 2,800 |
| Turnaround Time | 21–28 calendar days |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (Illumina) with CNV analysis |
| ICD-10-CM Code | E23.0 |
| LOINC Code | 81315-0 |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians